Adell Harriman & Carpenter Inc Amgen Inc Transaction History

Adell Harriman & Carpenter Inc

$1.33 Trillion
Q1 2025

A detailed history of Adell Harriman & Carpenter Inc transactions in Amgen Inc stock. As of the latest transaction made, Adell Harriman & Carpenter Inc holds 19,178 shares of AMGN stock, worth $5.53 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares

19,178

Previous 16,288 17.74%

Holding current value

$5.53 Million

Previous $4.25 Billion 40.74%

% of portfolio

0.45%

Previous 0.3%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 29, 2025	BUY	$258.59 - $327.36 $747,325 - $946,070	2,890 Added 17.74%	19,178 $5.98 Billion
Q4 2024 Jan 30, 2025	SELL	$258.78 - $328.31 $106,617 - $135,263	-412 Reduced 2.47%	16,288 $4.25 Billion
Q3 2024 Oct 25, 2024	SELL	$309.38 - $337.38 $168,612 - $183,872	-545 Reduced 3.16%	16,700 $5.38 Billion
Q2 2024 Aug 01, 2024	SELL	$262.75 - $319.31 $53,863 - $65,458	-205 Reduced 1.17%	17,245 $5.39 Billion
Q1 2024 Apr 25, 2024	BUY	$268.87 - $324.56 $50,278 - $60,692	187 Added 1.08%	17,450 $4.96 Billion
Q4 2023 Feb 05, 2024	BUY	$255.7 - $288.46 $43,469 - $49,038	170 Added 0.99%	17,263 $4.97 Billion
Q3 2023 Nov 07, 2023	BUY	$218.65 - $271.46 $143,215 - $177,806	655 Added 3.98%	17,093 $4.59 Billion
Q2 2023 Aug 04, 2023	SELL	$214.27 - $253.37 $200,342 - $236,900	-935 Reduced 5.38%	16,438 $3.7 Billion
Q1 2023 May 03, 2023	SELL	$225.79 - $275.2 $230,757 - $281,254	-1,022 Reduced 5.56%	17,373 $4.2 Billion
Q4 2022 Feb 03, 2023	SELL	$229.03 - $291.01 $253,765 - $322,439	-1,108 Reduced 5.68%	18,395 $4.83 Billion
Q3 2022 Nov 03, 2022	SELL	$224.46 - $253.15 $123,453 - $139,232	-550 Reduced 2.74%	19,503 $4.4 Billion
Q2 2022 Aug 03, 2022	SELL	$230.71 - $256.74 $94,360 - $105,006	-409 Reduced 2.0%	20,053 $4.88 Million
Q1 2022 Apr 29, 2022	SELL	$219.27 - $242.57 $316,845 - $350,513	-1,445 Reduced 6.6%	20,462 $4.95 Million
Q4 2021 Feb 16, 2022	SELL	$198.88 - $227.6 $550,499 - $629,996	-2,768 Reduced 11.22%	21,907 $4.93 Million
Q3 2021 Nov 05, 2021	SELL	$212.27 - $248.7 $704,736 - $825,684	-3,320 Reduced 11.86%	24,675 $5.25 Million
Q2 2021 Aug 10, 2021	SELL	$233.58 - $259.14 $142,250 - $157,816	-609 Reduced 2.13%	27,995 $6.82 Million
Q1 2021 May 03, 2021	SELL	$221.91 - $258.6 $88,542 - $103,181	-399 Reduced 1.38%	28,604 $7.12 Million
Q4 2020 Feb 05, 2021	SELL	$216.38 - $257.67 $29,211 - $34,785	-135 Reduced 0.46%	29,003 $6.67 Million
Q3 2020 Nov 06, 2020	BUY	$234.65 - $260.95 $284,865 - $316,793	1,214 Added 4.35%	29,138 $7.41 Million
Q2 2020 Aug 13, 2020	BUY	$197.81 - $242.74 $30,660 - $37,624	155 Added 0.56%	27,924 $6.59 Million
Q1 2020 May 07, 2020	SELL	$182.24 - $241.7 $232,356 - $308,167	-1,275 Reduced 4.39%	27,769 $5.63 Million
Q4 2019 Feb 07, 2020	SELL	$189.21 - $243.2 $632,150 - $812,531	-3,341 Reduced 10.32%	29,044 $7 Million
Q3 2019 Nov 08, 2019	BUY	$174.11 - $208.62 $198,485 - $237,826	1,140 Added 3.65%	32,385 $6.27 Million
Q2 2019 Aug 07, 2019	SELL	$166.7 - $195.41 $58,511 - $68,588	-351 Reduced 1.11%	31,245 $0
Q1 2019 May 07, 2019	SELL	$180.87 - $203.88 $149,036 - $167,997	-824 Reduced 2.54%	31,596 $0
Q4 2018 Feb 08, 2019	BUY	$178.4 - $208.25 $513,435 - $599,343	2,878 Added 9.74%	32,420 $6.31 Million
Q3 2018 Nov 14, 2018	BUY	$185.29 - $208.89 $14,267 - $16,084	77 Added 0.26%	29,542 $0
Q2 2018 Aug 06, 2018	BUY	$166.05 - $186.51 $204,407 - $229,593	1,231 Added 4.36%	29,465 $0
Q1 2018 May 08, 2018	SELL	$169.43 - $198.0 $5,252 - $6,138	-31 Reduced 0.11%	28,234 $0
Q4 2017 Feb 05, 2018	BUY	$168.79 - $188.59 $8,608 - $9,618	51 Added 0.18%	28,265 $0
Q3 2017 Nov 06, 2017	BUY	$167.29 - $191.0 $4.72 Million - $5.39 Million	28,214	28,214 $0

Others Institutions Holding AMGN

# of Institutions

3,309

Shares Held

429M

Call Options Held

8.06M

Put Options Held

7.7M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $154B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Adell Harriman & Carpenter Inc, based on Form 13F filings with the SEC.

News

Stay updated on Adell Harriman & Carpenter Inc with notifications on news.

Account

Adell Harriman & Carpenter Inc Amgen Inc Transaction History